Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies
The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create EcoRI (E +, E −) and XbaI (X +, X −) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E +X +, E +X −, E −X + and E −X − in the normolipidaemic popu...
Gespeichert in:
Veröffentlicht in: | Atherosclerosis 1988, Vol.69 (1), p.39-49 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 49 |
---|---|
container_issue | 1 |
container_start_page | 39 |
container_title | Atherosclerosis |
container_volume | 69 |
creator | Jenner, Kris Sidoli, Alessandro Ball, Madeline Rodriguez, Jose R. Pagani, Franco Giudici, G. Vergani, Carlo Mann, Jim Baralle, Francisco E. Shoulders, Carol C. |
description | The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create
EcoRI (E
+, E
−) and
XbaI (X
+, X
−) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E
+X
+, E
+X
−, E
−X
+ and E
−X
− in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the
EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B
Glu and apo B
Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X
+ allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X
− allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present. |
doi_str_mv | 10.1016/0021-9150(88)90287-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78156362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0021915088902870</els_id><sourcerecordid>78156362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</originalsourceid><addsrcrecordid>eNp9kMFu1DAURS1EVYaBPwDJC4RgkWInduxsKsEIaKWR2HRvvXGeqSGTBNtBKqt-Uz-JL6kzE82yK8v3nnf13iXkDWcXnPH6E2MlLxou2QetPzas1Kpgz8iKa9UUXGjxnKxOyAvyMsZfjDGhuD4n56VuZC3ViqTNLQSwCYP_B8kPPR0c_Yk9Jm_pHsJvDJH6nqZbpNX_-weKfTsj8x_GgX45wBSymiUf6BRx5h3sfXd30MdhnLpjdkxT6zG-ImcOuoivl3dNbr59vdlcFdsf3683n7eFrXSdCut4o6VDJ5um4kJAUyGAUEK4MntVWyJvLVfAQWkteS12Wu5QVLKulHDVmrw_xo5h-DNhTGbvo8Wugx6HKRqleSbrMoPiCNowxBjQmTH4fPyd4czMXZu5SDMXabQ2h64Ny2Nvl_xpt8f2NLSUm_13iw_RQucC9NbHE6a0yHfJjF0eMcxV_PUYTLQee4utD2iTaQf_9B6PueebSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78156362</pqid></control><display><type>article</type><title>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jenner, Kris ; Sidoli, Alessandro ; Ball, Madeline ; Rodriguez, Jose R. ; Pagani, Franco ; Giudici, G. ; Vergani, Carlo ; Mann, Jim ; Baralle, Francisco E. ; Shoulders, Carol C.</creator><creatorcontrib>Jenner, Kris ; Sidoli, Alessandro ; Ball, Madeline ; Rodriguez, Jose R. ; Pagani, Franco ; Giudici, G. ; Vergani, Carlo ; Mann, Jim ; Baralle, Francisco E. ; Shoulders, Carol C.</creatorcontrib><description>The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create
EcoRI (E
+, E
−) and
XbaI (X
+, X
−) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E
+X
+, E
+X
−, E
−X
+ and E
−X
− in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the
EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B
Glu and apo B
Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X
+ allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X
− allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/0021-9150(88)90287-0</identifier><identifier>PMID: 2895657</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ireland Ltd</publisher><subject>Adult ; Apo B genetic markers ; Apolipoproteins B - genetics ; Base Sequence ; Biological and medical sciences ; Disorders of blood lipids. Hyperlipoproteinemia ; Female ; Genetic Markers ; Haplotypes ; Humans ; Hyperlipidaemia ; Hyperlipoproteinemia Type II - genetics ; Hypervariable region ; Male ; Medical sciences ; Metabolic diseases ; Molecular Sequence Data ; Mutation ; Pedigree ; Polymorphism, Genetic ; Polymorphism, Restriction Fragment Length</subject><ispartof>Atherosclerosis, 1988, Vol.69 (1), p.39-49</ispartof><rights>1988</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</citedby><cites>FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0021-9150(88)90287-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7849935$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2895657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jenner, Kris</creatorcontrib><creatorcontrib>Sidoli, Alessandro</creatorcontrib><creatorcontrib>Ball, Madeline</creatorcontrib><creatorcontrib>Rodriguez, Jose R.</creatorcontrib><creatorcontrib>Pagani, Franco</creatorcontrib><creatorcontrib>Giudici, G.</creatorcontrib><creatorcontrib>Vergani, Carlo</creatorcontrib><creatorcontrib>Mann, Jim</creatorcontrib><creatorcontrib>Baralle, Francisco E.</creatorcontrib><creatorcontrib>Shoulders, Carol C.</creatorcontrib><title>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create
EcoRI (E
+, E
−) and
XbaI (X
+, X
−) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E
+X
+, E
+X
−, E
−X
+ and E
−X
− in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the
EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B
Glu and apo B
Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X
+ allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X
− allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.</description><subject>Adult</subject><subject>Apo B genetic markers</subject><subject>Apolipoproteins B - genetics</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Disorders of blood lipids. Hyperlipoproteinemia</subject><subject>Female</subject><subject>Genetic Markers</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Hyperlipidaemia</subject><subject>Hyperlipoproteinemia Type II - genetics</subject><subject>Hypervariable region</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>Polymorphism, Genetic</subject><subject>Polymorphism, Restriction Fragment Length</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAURS1EVYaBPwDJC4RgkWInduxsKsEIaKWR2HRvvXGeqSGTBNtBKqt-Uz-JL6kzE82yK8v3nnf13iXkDWcXnPH6E2MlLxou2QetPzas1Kpgz8iKa9UUXGjxnKxOyAvyMsZfjDGhuD4n56VuZC3ViqTNLQSwCYP_B8kPPR0c_Yk9Jm_pHsJvDJH6nqZbpNX_-weKfTsj8x_GgX45wBSymiUf6BRx5h3sfXd30MdhnLpjdkxT6zG-ImcOuoivl3dNbr59vdlcFdsf3683n7eFrXSdCut4o6VDJ5um4kJAUyGAUEK4MntVWyJvLVfAQWkteS12Wu5QVLKulHDVmrw_xo5h-DNhTGbvo8Wugx6HKRqleSbrMoPiCNowxBjQmTH4fPyd4czMXZu5SDMXabQ2h64Ny2Nvl_xpt8f2NLSUm_13iw_RQucC9NbHE6a0yHfJjF0eMcxV_PUYTLQee4utD2iTaQf_9B6PueebSw</recordid><startdate>1988</startdate><enddate>1988</enddate><creator>Jenner, Kris</creator><creator>Sidoli, Alessandro</creator><creator>Ball, Madeline</creator><creator>Rodriguez, Jose R.</creator><creator>Pagani, Franco</creator><creator>Giudici, G.</creator><creator>Vergani, Carlo</creator><creator>Mann, Jim</creator><creator>Baralle, Francisco E.</creator><creator>Shoulders, Carol C.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1988</creationdate><title>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</title><author>Jenner, Kris ; Sidoli, Alessandro ; Ball, Madeline ; Rodriguez, Jose R. ; Pagani, Franco ; Giudici, G. ; Vergani, Carlo ; Mann, Jim ; Baralle, Francisco E. ; Shoulders, Carol C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-cf1985fef5993144a93eaa4744f2cf13d2e1dc17a1a7885164b85be4356374f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Apo B genetic markers</topic><topic>Apolipoproteins B - genetics</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Disorders of blood lipids. Hyperlipoproteinemia</topic><topic>Female</topic><topic>Genetic Markers</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Hyperlipidaemia</topic><topic>Hyperlipoproteinemia Type II - genetics</topic><topic>Hypervariable region</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>Polymorphism, Genetic</topic><topic>Polymorphism, Restriction Fragment Length</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jenner, Kris</creatorcontrib><creatorcontrib>Sidoli, Alessandro</creatorcontrib><creatorcontrib>Ball, Madeline</creatorcontrib><creatorcontrib>Rodriguez, Jose R.</creatorcontrib><creatorcontrib>Pagani, Franco</creatorcontrib><creatorcontrib>Giudici, G.</creatorcontrib><creatorcontrib>Vergani, Carlo</creatorcontrib><creatorcontrib>Mann, Jim</creatorcontrib><creatorcontrib>Baralle, Francisco E.</creatorcontrib><creatorcontrib>Shoulders, Carol C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jenner, Kris</au><au>Sidoli, Alessandro</au><au>Ball, Madeline</au><au>Rodriguez, Jose R.</au><au>Pagani, Franco</au><au>Giudici, G.</au><au>Vergani, Carlo</au><au>Mann, Jim</au><au>Baralle, Francisco E.</au><au>Shoulders, Carol C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>1988</date><risdate>1988</risdate><volume>69</volume><issue>1</issue><spage>39</spage><epage>49</epage><pages>39-49</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>The 3′ end of the apo B gene is highly polymorphic. Two point mutations in the coding sequence of the gene create
EcoRI (E
+, E
−) and
XbaI (X
+, X
−) RFLPs. The two loci are in random association and the frequency of the four haplotypes, E
+X
+, E
+X
−, E
−X
+ and E
−X
− in the normolipidaemic population are 0.68, 0.30, 0.02 and 0.00, respectively. Although the polymorphic nucleotide underlying the
EcoRI RFLP creates an amino acid substitution in the apo B protein (Glu → Lys) in a region close to a putative LDL-receptor recognition site(s), we find no statistically significant difference in the frequency of the apo B
Glu and apo B
Lys alleles in hyperlipidaemic patients (familial hypercholesterolaemia, type IIA with no tendon xanthomas, IIB and probably IV) and the normolipidaemic population. In contrast, we confirm previous findings, that the X
+ allele is in linkage disequilibrium with a genetic locus that predisposes to the development of higher fasting plasma triglyceride levels than the X
− allele. We have characterized a highly polymorphic region immediately 3′ to the apo B gene. At least 5 alleles of this locus exist in the population and our family studies show it should be an extremely informative locus to use in studies where polymorphic or mutant apo B alleles are suspected to underly certain forms of familial hyperlipidaemia. DNA sequence analysis of this highly polymorphic locus shows that the variation is entirely attributable to the number of times the simple repeating sequence 5′-TTTATAATTAAAATATTTATAATTAAATAT-3′ is present.</abstract><cop>Amsterdam</cop><pub>Elsevier Ireland Ltd</pub><pmid>2895657</pmid><doi>10.1016/0021-9150(88)90287-0</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9150 |
ispartof | Atherosclerosis, 1988, Vol.69 (1), p.39-49 |
issn | 0021-9150 1879-1484 |
language | eng |
recordid | cdi_proquest_miscellaneous_78156362 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Apo B genetic markers Apolipoproteins B - genetics Base Sequence Biological and medical sciences Disorders of blood lipids. Hyperlipoproteinemia Female Genetic Markers Haplotypes Humans Hyperlipidaemia Hyperlipoproteinemia Type II - genetics Hypervariable region Male Medical sciences Metabolic diseases Molecular Sequence Data Mutation Pedigree Polymorphism, Genetic Polymorphism, Restriction Fragment Length |
title | Characterization of genetic markers in the 3′ end of the apo B gene and their use in family and population studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A23%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20genetic%20markers%20in%20the%203%E2%80%B2%20end%20of%20the%20apo%20B%20gene%20and%20their%20use%20in%20family%20and%20population%20studies&rft.jtitle=Atherosclerosis&rft.au=Jenner,%20Kris&rft.date=1988&rft.volume=69&rft.issue=1&rft.spage=39&rft.epage=49&rft.pages=39-49&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/0021-9150(88)90287-0&rft_dat=%3Cproquest_cross%3E78156362%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78156362&rft_id=info:pmid/2895657&rft_els_id=0021915088902870&rfr_iscdi=true |